Home

MARK DYNE

CIK 1032224 · last filed 2015-09-15

MARK DYNE is a corporate insider who has filed 11 SEC Form 4 insider transactions across 1 company since 2009. 20 SEC filings were submitted jointly with BRILLIANT DIGITAL ENTERTAINMENT INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

11

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
C/O BRILLIANT DIGITAL ENTERTAINMENT INC
6355 TOPANGA CANYON BLVD, SUITE 520
WOODLAND HILLS, CA 91367
Related Filers
BRILLIANT DIGITAL ENTERTAINMENT INC — 20 joint filings, latest 2006-02-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Protagenic Therapeutics, Inc.\new (ATRN) Delisted Director 12 — — $0 4 2010-09-30

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2015-09-15 — Grant (A) — $0
2014-08-18 — Grant (A) — $0
2013-08-16 — Grant (A) — $0
2013-07-16 — Buy (P) +8,333,333 $750.0K
2012-07-03 — Grant (A) — $0
2011-01-18 — Grant (A) — $0
2010-09-30 Protagenic Therapeutics, Inc.\new (ATRN) Delisted Grant (A) — $0 EDGAR
2010-06-07 Protagenic Therapeutics, Inc.\new (ATRN) Delisted Other (J) −20,000 $0 EDGAR
2009-09-21 Protagenic Therapeutics, Inc.\new (ATRN) Delisted Grant (A) +40,000 $0 EDGAR
2009-06-30 Protagenic Therapeutics, Inc.\new (ATRN) Delisted Grant (A) +3,892 $0 EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.